Pyrimethamine
پیریمتامین
🐛 Antiparasitic Products, Insecticides And RepellentsFolic acid antagonist (antiparasitic)
Market / country: 🇺🇸 USA
Daraprim (US)
🧮 Dose calculator
Toxoplasmosis · Regimen source: FDA Daraprim · Dosage and Administration
- • With 1–4 g of a sulfonamide (e.g. sulfadiazine) daily and folinic acid (leucovorin) in all patients. Then about half the dose for 4–5 weeks. Children: 1 mg/kg/day in two doses for 2–4 days, then half for about a month. FDA Daraprim · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to pyrimethamine; megaloblastic anaemia due to folate deficiency. FDA Daraprim · Contraindications
Warnings
- • Narrow therapeutic window; folate deficiency — folinic acid 5–15 mg daily; CBC twice weekly. FDA Daraprim · Warnings
Formulations
- 25 mg tablet (scored) — tablet 🇺🇸 USA FDA Daraprim · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Daraprim · Precautions/Warnings – Pregnancy
“DARAPRIM should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Daraprim · Precautions/Warnings – Nursing Mothers
“… rimethamine and from concurrent use of a sulfonamide with DARAPRIM for treatment of some patients with toxoplasmosis, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother (see WARNINGS and PRECAUTIONS:”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Daraprim · Precautions/Warnings – Pediatric Use
“See DOSAGE AND ADMINISTRATION section.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Daraprim · Precautions/Warnings – Geriatric Use
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA008578
- DailyMed (FDA label)FDA Daraprim
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDP01BD01
- Darooyab (Iran)Pyrimethamine
🇮🇷 Registered in Iran Darooyab · G-847/Pyrimethamine
Dosage forms with Iranian generic codes, per Darooyab.
- 01083 · PYRIMETHAMINE 25MG TAB · قرص پیریمتامین ۲۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Daraprim · How SuppliedFDA Daraprim · Dosage and AdministrationFDA Daraprim · ContraindicationsFDA Daraprim · WarningsFDA Daraprim · SPL approval / marketing categoryFDA Daraprim · Precautions/Warnings – PregnancyFDA Daraprim · Precautions/Warnings – Nursing MothersFDA Daraprim · Precautions/Warnings – Pediatric UseFDA Daraprim · Precautions/Warnings – Geriatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-847/Pyrimethamine
- Clinical review⚠ Unverified